![Stephen Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Cunningham
Plus aucun poste en cours
Health Technology
Profil
Stephen Cunningham was the founder of Engrail Therapeutics, Inc., serving as an Advisor since 2019.
Formerly, Dr. Cunningham worked at Chase Pharmaceuticals Corp.
as a Director.
Anciens postes connus de Stephen Cunningham
| Sociétés | Poste | Fin |
|---|---|---|
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases | Fondateur | - |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases | Health Technology |
